Quibim
Producer of whole body radiological image analysis based on Artificial Intelligence.
- B2B
- saas
- subscription
- health
- biotechnology
- medical devices
- health platform
- deep learning
- big data
- computer vision
- deep tech
- artificial intelligence
- mobile app
- biotechnology
- horizon europe
- dt and ls
- core ai
- ai applications
- oncology
- eit ecosystem
- drug development
- eit health
- direct-to-consumer
- health it
- ai drug discovery
- tech for hospitals and clinics
- tech for medical professionals
- techbio
- tech for biotech and pharma
- physician support tools
- health diagnostics
- medical imaging
- techbio drug discovery
- clinical decision support
- precision medicine
- ai for medical imaging
- clinical trials
- radiology
- digital twin
- treatment assistance
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | $50.0m | Series A | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 329 % | 31 % | 34 % | 1 % | 149 % | 50 % | 40 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 45 % | (73 %) | (122 %) | (288 %) | (262 %) | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 21 % | (116 %) | (245 %) | (426 %) | (330 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Quibim operates in the healthcare technology sector, specializing in advanced medical imaging solutions. The company serves a diverse range of clients, including hospitals, research institutions, and radiology departments. Quibim's core offering is an AI-driven ecosystem that provides specialized imaging suites for different body parts, enabling comprehensive and precise analysis. This technology generates objective and quantifiable clinical data, facilitating better diagnosis and treatment planning. The business model is primarily B2B, generating revenue through the sale of its imaging software solutions and associated services. Quibim's market is global, targeting healthcare providers looking to enhance their imaging capabilities with cutting-edge AI technology. The company differentiates itself by offering a holistic imaging solution that covers the entire body, unlike competitors who may focus on specific areas.
Keywords: AI-driven, medical imaging, healthcare technology, radiology, clinical data, specialized suites, B2B, global market, diagnosis, treatment planning.